Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel T Hwang

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Cellular and Molecular Medicine|May 22, 2019
Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in miceYan Zhou, Dan Han, Taylor Follansbee, et al.
Trials|March 22, 2019
A single-blind, dose-escalation, phase I study of high-fluence light-emitting diode-red light on Caucasian non-Hispanic skin: study protocol for a randomized controlled trialErica B Wang, Ramanjot Kaur, Julie Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2011
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathwaysLuke J Drury, Joshua J Ziarek, Stéphanie Gravel, et al.
Journal of Dermatological Science|February 12, 2020
Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancerSebastian Yu, Xuesong Wu, Zhenrui Shi, et al.
The Journal of Investigative Dermatology|April 23, 2021
New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted TherapiesDi Yan, Andrew Blauvelt, Amit K Dey, et al.
The Journal of Investigative Dermatology|April 28, 2020
Differential Requirement for CCR6 in IL-23-Mediated Skin and Joint InflammationZhenrui Shi, Emma Garcia-Melchor, Xuesong Wu, et al.
Journal of Immunological Methods|March 2, 2023
A modified ELISA assay differentiates CCL20 locked dimers from wild-type monomersXuesong Wu, William R Clarke, Chad A Koplinski, et al.
Nature Communications|March 27, 2026
Smad7-based biologic targeting epidermis and stroma promotes healing of diabetic wounds in mice and pigsYao Ke, Ben-Zheng Li, Fulun Li, et al.
The Journal of Rheumatology|August 1, 2024
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic DiseaseDaniela Kampel Stolnicki, Laura C Coates, Charlotte E Gollins, et al.
The Journal of Investigative Dermatology|November 22, 2021
Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6-Mediated Trafficking of T CellsZhenrui Shi, Xuesong Wu, Chun-Yi Wu, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Cellular and Molecular Medicine|May 22, 2019
Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in miceYan Zhou, Dan Han, Taylor Follansbee, et al.
Trials|March 22, 2019
A single-blind, dose-escalation, phase I study of high-fluence light-emitting diode-red light on Caucasian non-Hispanic skin: study protocol for a randomized controlled trialErica B Wang, Ramanjot Kaur, Julie Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2011
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathwaysLuke J Drury, Joshua J Ziarek, Stéphanie Gravel, et al.
Journal of Dermatological Science|February 12, 2020
Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancerSebastian Yu, Xuesong Wu, Zhenrui Shi, et al.
The Journal of Investigative Dermatology|April 23, 2021
New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted TherapiesDi Yan, Andrew Blauvelt, Amit K Dey, et al.
The Journal of Investigative Dermatology|April 28, 2020
Differential Requirement for CCR6 in IL-23-Mediated Skin and Joint InflammationZhenrui Shi, Emma Garcia-Melchor, Xuesong Wu, et al.
Journal of Immunological Methods|March 2, 2023
A modified ELISA assay differentiates CCL20 locked dimers from wild-type monomersXuesong Wu, William R Clarke, Chad A Koplinski, et al.
Nature Communications|March 27, 2026
Smad7-based biologic targeting epidermis and stroma promotes healing of diabetic wounds in mice and pigsYao Ke, Ben-Zheng Li, Fulun Li, et al.
The Journal of Rheumatology|August 1, 2024
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic DiseaseDaniela Kampel Stolnicki, Laura C Coates, Charlotte E Gollins, et al.
The Journal of Investigative Dermatology|November 22, 2021
Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6-Mediated Trafficking of T CellsZhenrui Shi, Xuesong Wu, Chun-Yi Wu, et al.
Pageof 4